Idea

Over half a million people die every year because of seasonal influenza. The solution is vaccination.

However, producing enough doses of vaccine can be challenging. Influenza vaccines are grown in eggs and up to two eggs are required to produce one single dose of vaccine. Our solution is a premium high-yield egg that increases vaccine growth tenfold. This will increase profitability for vaccine companies by improving production efficiency across the supply chain, which means more vaccine in less time.

Vaximiser will enhance the capacity to respond to disease outbreaks and help to protect the world from the next pandemic.

Andrew Bean, Luis Malaver-Ortega, Lyndon Judd.

Team

  • Andy Bean: Over 25 years in immunology and vaccine development.
  • Tim Doran: World leader in poultry genetics to improve health and welfare.
  • Luis Malaver-Ortega : Molecular & cellular biologist with 10 years experience in the field.
  • Lyndon Judd : Over 15 years in business development and tech transfer.

[Music plays and text appears: ON powered by CSIRO]

[Image appears of Andrew Bean talking to the camera and then the camera pans over the audience and text appears: Andrew Bean, Team Vaximiser]

Andrew Bean:  My name’s Andrew Bean and I’m from the Health and Biosecurity Business Unit. 

[Images continue to flash through of the audience and then the image changes to show Andrew Bean talking to the camera again]

We’re developing new processes to help maximise vaccine production so that we’ll have cheaper vaccines that are available for all people. 

[Image changes to show hands holding a “The future is ON” brochure and then the image changes to show Andrew Bean talking into the microphone surrounded by Team Vaximiser]

Vaccine production uses methods that were developed in the 1920s and it’s now time to bring that into the 21st century. 

[Images flash through of the audience, Andrew Bean talking into the microphone and Andrew Bean talking to the camera]

At the start of the ON process we had a proof of concept idea but we didn’t know what its’ value was. 

[Images flash through of Team Vaximiser with Andrew Bean talking into the microphone, the audience and Andrew Bean talking into the microphone again]

Flu vaccines are grown in eggs and using clever biology we’ve developed an egg that maximises vaccine production. 

[Image changes to show a back view of Team Vaximiser looking out over the audience and then the image changes to show a front view of the Team Vaximiser with Andrew Bean talking into the microphone]

What ON did for us was to test that, to go out there and validate it. 

[Image changes to show a back view of Team Vaximiser looking out over the audience and then the image changes to show Andrew Bean talking to the camera and then the image changes to show Team Vaximiser with Andrew Bean talking into the microphone]

It really gave us the impetus to develop it and expand it into a true product area where we could then interact with industry and that’s the phase we’re at right now. 

[Image changes to show the audience and then the image changes to show Andrew Bean talking into the microphone]

We’re hoping to get the numbers that we need to go into industrial trials with some of the largest vaccine producers in the world.

[Music plays and clapping can be heard]

[Image changes to show the audience clapping]

[Test appears: The future is ON powered by CSIRO, csiro.au/on]

Andrew explains how ON helped his team accelerate their science and technology

Contact ON

Your contact details

First name must be filled in

We'll need to know what you want to contact us about so we can give you an answer.